Tag Archives: HBI

Hot Medical Stocks To Invest In 2019

Shares of Suven Life Sciences touched 52-week high of Rs 267, rising 3.5 percent intraday Thursday as company secured product and process patents in Canada and USA.

The company has been granted 1 product patent from Canada and 1 process patent from USA corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2034.

Venkat Jasti, CEO of Suven Life Sciences said, “We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally.”

At 11:50 hrs Suven Life Sciences was quoting at Rs 264.40, up Rs 6.40, or 2.48 percent on the BSE.

Hot Medical Stocks To Invest In 2019: PowerShares DWA Technology Momentum ETF (PTF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News headlines about PowerShares Dynamic Tech Sec (NASDAQ:PTF) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PowerShares Dynamic Tech Sec earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave media headlines about the company an impact score of 48.5554072096128 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Hot Medical Stocks To Invest In 2019: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Timothy Green]

    Basic apparel and activewear manufacturer Hanesbrands (NYSE:HBI) didn’t disappoint when it reported its fourth-quarter results Thursday morning. Strong organic sales growth, driven by its Champion brand of activewear and its international business, led to margin improvements and earnings growth, excluding the effects of a higher tax rate. Hanesbrands easily beat analyst estimates for both revenue and earnings, and its revenue guidance was ahead of expectations.

  • [By Stephan Byrd]

    Morgan Stanley increased its position in shares of Hanesbrands Inc. (NYSE:HBI) by 13.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,095,675 shares of the textile maker’s stock after acquiring an additional 362,960 shares during the period. Morgan Stanley owned about 0.86% of Hanesbrands worth $68,166,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By John Ballard]

    Shares of Hanesbrands (NYSE:HBI) climbed 24% in value last month, according to data provided by S&P Global Market Intelligence.

    Investors got excited about the company’s turnaround efforts when it issued a better-than-expected fourth-quarter earnings report in early February.

Hot Medical Stocks To Invest In 2019: National Health Investors, Inc.(NHI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    National Health Investors Inc  (NYSE:NHI)Q4 2018 Earnings Conference CallFeb. 19, 2019, 12:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Colleen Schaller — Director, Investor Relations

  • [By Shane Hupp]

    Virginia Retirement Systems ET AL lifted its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,300 shares of the real estate investment trust’s stock after acquiring an additional 10,700 shares during the period. Virginia Retirement Systems ET AL owned approximately 0.28% of National Health Investors worth $7,826,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Shares of National Health Investors, Inc. (NYSE:NHI) have received a consensus rating of “Hold” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $71.43.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on National Health Investors (NHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Invest In 2019: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rhumbline Advisers grew its position in shares of J B Hunt Transport Services Inc (NASDAQ:JBHT) by 7.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 194,057 shares of the transportation company’s stock after purchasing an additional 13,292 shares during the period. Rhumbline Advisers owned 0.18% of J B Hunt Transport Services worth $23,588,000 at the end of the most recent quarter.

  • [By ]

    In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) , Lennar (LEN) , Toll Brothers (TOL) , Tyson Foods (TSN) , JB Hunt Transport Services (JBHT) and International Paper (IP) .

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

  • [By ]

    JB Hunt Transport Services (JBHT) : “I’m sticking with it.”

    Opko Health (OPK) : “I’ve been waiting for these guys to come back on the show and tell us why we should buy.”

  • [By ]

    But then there’s the little-known trucking company JB Hunt (JBHT) , which popped 6.1% because the company saw some surprise growth that no one was expecting. That news was so strong, FedEx (FDX) and XPO Logistics (XPO) also rose 2.2% and 4.6%.

Hot Medical Stocks To Invest In 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

  • [By Logan Wallace]

    York Water (NASDAQ:YORW) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Saturday.

  • [By Max Byerly]

    PENNON GRP PLC/ADR (OTCMKTS:PEGRY) and York Water (NASDAQ:YORW) are both utilities companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Top 10 Undervalued Stocks To Watch For 2019

The reason why the growth stocks do so much better is that they seem to show gains in value in the hundreds of percent each decade. In contrast, it is an unusual bargain that is as much as 50 percent undervalued. The cumulative effect of this simple arithmetic should be obvious. – Philip Fisher (the Father of Growth Investing)

On Jan 05, 2018, the share price of Crispr Therapeutics (NASDAQ:CRSP), a bioscience focusing on gene-editing and CAR-T to treat serious conditions such as cancers and genetic diseases, continued its rally. The stock added another $2.90 (over 12% profits) to value at $26.81 for the said trading session. Since we recommended the company on Nov. 27, 2017 (just over a month) to subscribers of Integrated BioSci Investing, the stock added another $7.26 (or 37% in capital appreciation). This robust run-up is interesting because, on Jan. 04, 2018, the company announced that the 5M additional common shares issued on Jan 03 will be priced at $22.75.

Top 10 Undervalued Stocks To Watch For 2019: Internap Network Services Corporation(INAP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Internap (NASDAQ:INAP) issued its quarterly earnings data on Thursday. The information technology services provider reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.13), MarketWatch Earnings reports. The business had revenue of $74.20 million for the quarter, compared to analyst estimates of $73.99 million. Internap had a negative return on equity of 271.76% and a negative net margin of 16.15%. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.02) earnings per share.

  • [By Shane Hupp]

    GDS (NASDAQ: INAP) and Internap (NASDAQ:INAP) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Internap (INAP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Shares of Internap Corp (NASDAQ:INAP) saw unusually-strong trading volume on Tuesday . Approximately 1,086,029 shares traded hands during mid-day trading, an increase of 306% from the previous session’s volume of 267,673 shares.The stock last traded at $5.85 and had previously closed at $5.32.

  • [By Stephan Byrd]

    Internap Corp (NASDAQ:INAP) has received an average rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $28.00.

Top 10 Undervalued Stocks To Watch For 2019: KLX Inc.(KLXI)

Advisors’ Opinion:

  • [By Logan Wallace]

    OppenheimerFunds Inc. decreased its position in KLX Inc (NASDAQ:KLXI) by 16.2% in the 1st quarter, Holdings Channel reports. The firm owned 7,067 shares of the aerospace company’s stock after selling 1,367 shares during the period. OppenheimerFunds Inc.’s holdings in KLX were worth $502,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Rich Smith]

    KLX Inc. (NASDAQ:KLXI) stock closed 15.2% lower on Monday. That sounds like bad news, but really isn’t. Here’s why.

    So what

    KLX is a strange beast, as it comprises two main business units. The Aerospace Solutions Group distributes small airplane components such as bolts, clips, hinges, and screws. With $1.4 billion in annual sales, this is KLX’s largest business unit — and it’s selling out to Boeing in a $4.25 billion deal initially expected to close sometime in this current third quarter of 2018  — later postponed to Q4.

  • [By Shane Hupp]

    KLX (NASDAQ:KLXI) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Friday.

  • [By Max Byerly]

    BidaskClub downgraded shares of KLX (NASDAQ:KLXI) from a buy rating to a hold rating in a report released on Tuesday morning.

    KLXI has been the subject of several other reports. SunTrust Banks cut shares of KLX from a buy rating to a hold rating and set a $53.00 target price for the company. in a report on Wednesday, May 2nd. Zacks Investment Research cut shares of KLX from a buy rating to a hold rating in a report on Saturday, February 17th. TheStreet cut shares of KLX from a b rating to a c+ rating in a report on Tuesday, March 6th. Finally, Jefferies Group upgraded shares of KLX from a hold rating to a buy rating in a report on Wednesday, March 7th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $66.50.

Top 10 Undervalued Stocks To Watch For 2019: Discover Financial Services(DFS)

Advisors’ Opinion:

  • [By Matthew Cochrane]

    Over the past several quarters, Discover Financial Services (NYSE:DFS) has struggled to strike the proper balance between growing its loan portfolios and keeping its credit default risks in check. At least, that’s what Wall Street would have you believe. Discover’s management, however, maintains credit risk concerns are overblown. Meanwhile, the company continues to grow its loan portfolios at steady clips.

  • [By Joseph Griffin]

    DFS Furniture (LON:DFS)‘s stock had its “buy” rating reissued by analysts at Peel Hunt in a research note issued to investors on Thursday.

  • [By ]

    Selected examples: (BXP) , (DFS) , (HST) , (MA) , (TXN) , (USB) .

    Inflation Is a Key Risk

    Execs were most worried about inflation, as they should be.

Top 10 Undervalued Stocks To Watch For 2019: Gulfport Energy Corporation(GPOR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Liberty Mutual Group Asset Management Inc. lowered its stake in Gulfport Energy Co. (NASDAQ:GPOR) by 22.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,452 shares of the oil and gas producer’s stock after selling 9,320 shares during the quarter. Liberty Mutual Group Asset Management Inc.’s holdings in Gulfport Energy were worth $313,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Gulfport Energy (NASDAQ: GPOR) and Callitas Health (OTCMKTS:MPHMF) are both small-cap oils/energy companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership.

  • [By Shane Hupp]

    Gulfport Energy Co. (NASDAQ:GPOR) saw some unusual options trading activity on Monday. Stock investors bought 43,045 call options on the stock. This is an increase of approximately 1,866% compared to the typical volume of 2,190 call options.

  • [By Max Byerly]

    Liberum Capital reissued their hold rating on shares of Great Portland Estates (LON:GPOR) in a research note published on Wednesday morning.

    GPOR has been the subject of a number of other reports. Barclays increased their price objective on shares of Great Portland Estates from GBX 560 ($7.51) to GBX 580 ($7.78) and gave the company an underweight rating in a report on Thursday, February 22nd. Deutsche Bank reaffirmed a hold rating on shares of Great Portland Estates in a report on Friday, March 2nd. Goldman Sachs Group cut their price objective on shares of Great Portland Estates from GBX 675 ($9.06) to GBX 665 ($8.92) and set a neutral rating for the company in a report on Wednesday, March 14th. Morgan Stanley increased their price objective on shares of Great Portland Estates from GBX 620 ($8.32) to GBX 660 ($8.86) and gave the company an underweight rating in a report on Tuesday, March 13th. Finally, Citigroup raised their target price on shares of Great Portland Estates from GBX 700 ($9.39) to GBX 735 ($9.86) and gave the company a neutral rating in a report on Wednesday, May 2nd. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. Great Portland Estates has a consensus rating of Hold and a consensus target price of GBX 662.15 ($8.88).

  • [By Logan Wallace]

    Gulfport Energy Co. (NASDAQ:GPOR) – Stock analysts at Seaport Global Securities upped their Q3 2018 earnings per share estimates for Gulfport Energy in a research note issued on Wednesday, May 23rd. Seaport Global Securities analyst M. Kelly now expects that the oil and gas producer will post earnings of $0.33 per share for the quarter, up from their prior estimate of $0.22. Seaport Global Securities also issued estimates for Gulfport Energy’s Q4 2018 earnings at $0.43 EPS, FY2018 earnings at $1.63 EPS, Q2 2019 earnings at $0.28 EPS, Q3 2019 earnings at $0.28 EPS, Q4 2019 earnings at $0.35 EPS and FY2019 earnings at $1.22 EPS.

  • [By Paul Ausick]

    Gulfport Energy Corp. (NASDAQ: GPOR) traded down about 10% Tuesday and posted a new 52-week low of $10.90 after closing Monday at $12.12. The stock’s 52-week high is $9.75. Volume was over 12 million, nearly four times the daily average of about 3.4million shares. The company had no specific news announced its capital budget and a stock repurchase program after markets closed Monday.

Top 10 Undervalued Stocks To Watch For 2019: ITUS Corporation(ITUS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ITUS Corp (NASDAQ:ITUS) CEO Amit Kumar bought 4,480 shares of ITUS stock in a transaction dated Wednesday, September 12th. The shares were purchased at an average cost of $3.99 per share, for a total transaction of $17,875.20. Following the completion of the transaction, the chief executive officer now owns 128,888 shares of the company’s stock, valued at approximately $514,263.12. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

Top 10 Undervalued Stocks To Watch For 2019: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Ultragenyx Pharmaceutical alerts:

    Burosumab Improves Outcomes in Children with XLH in Phase 2 Trial (raredr.com) RARE Stock Is on the Verge of Breaking Out Toward Higher Prices (profitconfidential.com) Burosumab may benefit children with X-linked hypophosphatemia (medicalxpress.com) A Look Inside the Quant Data For Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) (parkcitycaller.com) Ultragenyx Pharmaceutical Inc. (RARE)- Stock in the Trader’s Radar (nasdaqfortune.com)

    A number of research firms have recently weighed in on RARE. ValuEngine raised Ultragenyx Pharmaceutical from a “hold” rating to a “buy” rating in a report on Saturday. BidaskClub raised Ultragenyx Pharmaceutical from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Barclays raised Ultragenyx Pharmaceutical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $62.00 to $74.00 in a report on Friday, May 11th. Goldman Sachs Group began coverage on Ultragenyx Pharmaceutical in a report on Thursday, May 10th. They set a “neutral” rating and a $63.00 target price for the company. Finally, Zacks Investment Research downgraded Ultragenyx Pharmaceutical from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $70.06.

  • [By Shane Hupp]

    Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ultragenyx launched its second drug, Crysvita, in the United States to treat X-linked hypophosphatemia (XLH) in April. We are optimistic on the drug’s uptake. The drug was also approved in the EU in February on a conditional basis. In May, the company announced positive phase II data from the drug in pediatric setting, but according to the FDA those were not sufficient to support an NDA. Thus, the company is in discussions with FDA and EMA, which would provide further clarity regarding whether an additional study would be required for the approval. The company also remains focused on its two-gene therapy programs — DTX301 for ornithine transcarbamylase deficiency and DTX401 for glycogen storage disease type Ia. However, developmental or regulatory setbacks could result in higher operating expenses and the need for additional capital. Loss estimates have narrowed ahead of  Q3 earnings release.”

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.

    A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Chris Lange]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is expected to report Phase 2 data from all its tumor-induced osteomalacia patients. Shares of Ultragenyx closed Friday at $76.87, in a 52-week range of $41.67 to $86.10 and with a consensus analyst target of $68.74.

Top 10 Undervalued Stocks To Watch For 2019: Cytosorbents Corporation(CTSO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cytosorbents Corp (NASDAQ:CTSO) COO Vincent Capponi sold 9,565 shares of the company’s stock in a transaction that occurred on Tuesday, August 28th. The shares were sold at an average price of $13.00, for a total value of $124,345.00. Following the completion of the transaction, the chief operating officer now owns 342,333 shares in the company, valued at approximately $4,450,329. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Motley Fool Transcribers]

    Cytosorbents Corp  (NASDAQ:CTSO)Q4 2018 Earnings Conference CallMarch 07, 2019, 4:45 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Cytosorbents (NASDAQ:CTSO) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Thursday.

Top 10 Undervalued Stocks To Watch For 2019: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wall Street seemed to phone it in on Monday, with low volume and fairly modest moves for most major benchmarks reflecting the fact that many federal and state government offices were closed for a holiday. Interest rates stabilized after a substantial jump last week, but market participants are still working through the potential consequences of the rate rise that resulted in 10-year Treasury yields hitting their highest levels since the early 2010s. Moreover, some negative news regarding individual companies weighed on sentiment. Square (NYSE:SQ), Ebix (NASDAQ:EBIX), and iRobot (NASDAQ:IRBT) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Motley Fool Transcribers]

    Ebix Inc  (NASDAQ:EBIX)Q4 2018 Earnings Conference CallMarch 01, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Shares of Ebix Inc (NASDAQ:EBIX) were down 5.8% during mid-day trading on Tuesday . The stock traded as low as $57.66 and last traded at $61.47. Approximately 18,499 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 189,931 shares. The stock had previously closed at $58.10.

  • [By Shane Hupp]

    Ebix (NASDAQ: EBIX) and Godaddy (NYSE:GDDY) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

  • [By Shane Hupp]

    Shares of Ebix Inc (NASDAQ:EBIX) have been assigned a consensus recommendation of “Buy” from the six ratings firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $100.00.

  • [By Ethan Ryder]

    Ebix (NASDAQ:EBIX) issued its earnings results on Wednesday. The technology company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.01), MarketWatch Earnings reports. The business had revenue of $108.23 million for the quarter, compared to analysts’ expectations of $106.81 million. Ebix had a return on equity of 20.67% and a net margin of 27.65%. Ebix’s revenue for the quarter was up 36.8% on a year-over-year basis.

Top 10 Undervalued Stocks To Watch For 2019: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wall Street started the week on a muted note on Monday, as major benchmarks generally closed slightly down. Much of the attention among investors was on the bond market, where 10-year Treasury yields rose as high as 2.99%, signaling to some the possibility of much higher financing costs that could punish companies that overextended their balance sheets with debt when rates were much lower. Yet some individual companies had good news that sent their shares higher. McDermott International (NYSE:MDR), Box (NYSE:BOX), and Hanesbrands (NYSE:HBI) were among the best performers on the day. Here’s why they did so well.

  • [By Stephan Byrd]

    Morgan Stanley increased its position in shares of Hanesbrands Inc. (NYSE:HBI) by 13.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,095,675 shares of the textile maker’s stock after acquiring an additional 362,960 shares during the period. Morgan Stanley owned about 0.86% of Hanesbrands worth $68,166,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Hanesbrands (HBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Hanesbrands (HBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Noonan]

    The strategy might not produce huge gains overnight, but patient investors can see strong returns with a value-focused, buy-to-hold approach to dividend stocks. Within that mold, investors seeking solid, income-generating stocks should consider establishing or adding to positions in Hanesbrands (NYSE:HBI) and AT&T (NYSE:T) — two companies that are consistently profitable, trade at non-prohibitive valuations, and pay sizable dividends. 

  • [By Keith Noonan]

    For this dive into promising income-generating stocks, I’ll be looking at three companies that have recently been making headlines for their strong performances. Two are technology giants that are benefiting from the growth of recurring revenue streams — Cisco Systems (NASDAQ:CSCO) and Microsoft (NASDAQ:MSFT) — and the other is an apparel stalwart on the rebound as one of its key lines is heating up — Hanesbrands (NYSE:HBI).

Top 10 Undervalued Stocks To Watch For 2019: The First of Long Island Corporation(FLIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    1ST RES BK EXTO/SH (OTCMKTS:FRSB) and First of Long Island (NASDAQ:FLIC) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “First of Long Island Corp (FLIC) Position Trimmed by ClariVest Asset Management LLC” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/4167612/first-of-long-island-corp-flic-position-trimmed-by-clarivest-asset-management-llc.html.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First of Long Island (FLIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    First of Long Island Corp (NASDAQ:FLIC) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $21.30 and last traded at $21.60, with a volume of 237 shares. The stock had previously closed at $21.50.

  • [By Stephan Byrd]

    First of Long Island (NASDAQ:FLIC) and 1ST RES BK EXTO/SH (OTCMKTS:FRSB) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Top 10 Safest Stocks For 2018

We spoke with the company Nvidia (NASDAQ:NVDA) in late June and we fell in love all over again. As an analyst who lives and dies by working through the earnings model to figure out earnings numbers it doesn’t get much better than Nvidia. The Street has been low, is currently low, and probably is still very low on the coming quarters as well. On a simple PE valuation with no fancy numbers we’re about to show you how this stock can easily be another double from here in the next 12 months.

We Give Nvidia Our Official Highest Rating: Love

We love it.

Top 10 Safest Stocks For 2018: Jacobs Engineering Group Inc.(JEC)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Jacobs Engineering Group Inc. (NYSE: JEC) which rose about 9% to $64.92. The stocks 52-week range is $49.31 to $65.29. Volume was1.8 million compared to its average volume of less than 1 million.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

Top 10 Safest Stocks For 2018: China Automotive Systems, Inc.(CAAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    China Automotive Systems, Inc. (NASDAQ: CAAS) is projected to post its quarterly earnings at $0.20 per share on revenue of $108.22 million.

    Affimed NV (NASDAQ: AFMD) is projected to post a quarterly loss at $0.18 per share on revenue of $1.71 million.

Top 10 Safest Stocks For 2018: CenturyLink, Inc.(CTL)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Originally a rural telecom, CenturyLink (CTL) has grown via acquisitions to become a major provider of broadband, voice, video, and data.

    It now provides services residential and business customers over a 250,000-route-mile US fiber network and a 300,000 mile international network.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday CenturyLink, Inc. (NYSE: CTL) which rose over 8% to $15.88. The stocks 52-week range is $13.16 to $27.61. Volume was over 25 million compared to its average volume of 14.6 million.

  • [By Paul Ausick]

    CenturyLink Inc. (NYSE: CTL) dropped about 7.8% Monday to post a new 52-week low of $17.07 after closing at $18.51 on Friday. The 52-week high is $30.39. Volume was around 21 million, about double the daily average of around 11 million. The company’s $34 billion acquisition of Level 3 Communications received FCC approval, but the company was hit with a charge of securities fraud.

Top 10 Safest Stocks For 2018: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.26 per share on revenue of $17.71 billion before the opening bell. Citigroup shares rose 0.30 percent to $67.22 in after-hours trading.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.65 per share on revenue of $25.61 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.48 percent to $93.55 in after-hours trading.
    Cyberark Software Ltd (NASDAQ: CYBR) lowered its guidance for the second quarter. The company now expects total revenue of $57.0 million to $57.5 million, versus earlier guidance of $61.0 million to $62.0 million. Cyberark shares dipped 17.65 percent to $42.00 in the after-hours trading session.
    Before the opening bell, First Republic Bank (NYSE: FRC) is projected to report quarterly earnings at $1.1 per share on revenue of $675.70 million. First Republic Bank shares dropped 0.80 percent to close at $101.35 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Safest Stocks For 2018: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

Top 10 Safest Stocks For 2018: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Rich Duprey]

    If a stock falls hard, particularly one with a durable name in its industry, it could be an opportunity to pick up shares on the cheap. But sometimes, a stock trades at a discount for a very good reason, so let’s take a look at Whirlpool (NYSE:WHR), Hanesbrands (NYSE:HBI), and Vista Outdoor (NYSE:VSTO) to see if they are good values at these lower prices — or just value traps.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

Top 10 Safest Stocks For 2018: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By Chris Lange]

    Biogen Inc. (NASDAQ: BIIB) had its short interest increase to 2.63 million shares from the previous 2.36 million. The stock closed Friday at $305.20, within a 52-week range of $223.02 to $333.65.

  • [By Ben Levisohn]

    Biogen (BIIB) has dropped 2.2% to $286.16 after getting cut to Market Perform from Outperform at Leerink, and to Equal Weight from Overweight at Morgan Stanley.

  • [By WWW.MONEYSHOW.COM]

    Biogen (BIIB)

    Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases and autoimmune disorders.

  • [By WWW.THESTREET.COM]

    Breakups have the potential to create a lot of value. Just look at what Biogen (BIIB) did with its hemophilia franchise. Spun out as Bioverativ (BIVV) , shares started trading earlier this year. The stock has climbed some 23% on seemingly no news, Cramer noted.

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Biogen Inc. (NASDAQ: BIIB) which traded down nearly 4% at $329.58. The stocks 52-week range is $244.28 to $348.84. Volume was 1.2 million matching the daily average of 1.2 million shares.

Top 10 Safest Stocks For 2018: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Consumers across the nation know Flowers Foods (NYSE:FLO) from its Wonder bread, Tastykake snack cakes, and Nature’s Own bakery brands. Yet the truly novel thing about Flowers is how it has done such a good job of building up a national presence in an industry that is typically dominated by local competition. Coming into Monday’s fourth-quarter financial report, Flowers investors were hoping to see at least some growth in sales and earnings, but the bakery company wasn’t able to deliver the pace of expansion that most shareholders really want to see.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Safest Stocks For 2018: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

Top 10 Safest Stocks For 2018: Gogo Inc.(GOGO)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for small capin-flight WiFi stockGogo Inc (NASDAQ: GOGO) is scheduled for before the market opens onMonday (February 27th). Last summer, American Airlines did a deal with rival ViaSat, Inc (NASDAQ: VSAT) to provide Internet access on about 100 new Boeing jets. To add to the turbulence, Moody’s Investors Service assigned a B3 Corporate Family Rating, a B3-PD Probability of Default Rating and a SGL-2 Speculative Grade Liquidity Rating to Gogo Inc plus assigned a B2 (LGD3) rating to the Company’s $500 senior secured note offering (after a planned sale of $525 millionin junk bonds fell through). The Ratings Action noted:

  • [By Steve Symington]

    Shares of Gogo Inc. (NASDAQ:GOGO) were up 18.3% as of 1:30 p.m. EST Monday after the in-flight connectivity specialist announced stronger-than-expected fourth-quarter 2016 results.

  • [By Lee Jackson]

    Gogo Inc. (NASDAQ: GOGO) had a director purchasing a total of 300,000 shares at $9.69 per share. The total for the purchase was posted at $3 million.Gogo provides communications services to the commercial and business aviation markets in the United States and internationally. Itsstock was trading on Friday at $8.85.

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By Dan Caplinger]

    Monday started the new week on a positive note, as the stock market once again recovered from early declines to post advances. The Dow Jones Industrials extended its string of record closes to 12 consecutive days in the wake of favorable comments from Warren Buffett about the valuation of the market. Moves within the Trump administration to transfer spending to the Defense Department also bolstered the overall market mood. In addition, good news from certain companies helped to sustain positive sentiment overall, and Advanced Micro Devices (NASDAQ:AMD), Windstream Holdings (NASDAQ:WIN), and Gogo (NASDAQ:GOGO) were among the top performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Lisa Levin]

    Shares of Gogo Inc (NASDAQ: GOGO) got a boost, shooting up 19 percent to $10.85 after the company reported a narrower-than-expected quarterly loss.

what stocks to buy now

I want to tell you about a terrific way to find clues that can help you discover what you’d be happiest, and most fulfilled, doing in your career. It’s called The Life Stories Exercise (also known as The Seven Stories Exercise, trademarked by The 5 O’Clock Club).

Credit: Shutterstock

This powerful (and free!) tool won’t tell you what type of job to do next, but it will show you which factors to look for to have a satisfying career with purpose. I often use this exercise with clients in my semi-retirement coaching practice. And I’d say that some version of it is at the core of most coaching work — and career advice books.

In a moment, I’ll provide step-by-step instructions for the exercise and explain the Personal Profile Summary worksheet that accompanies this post. But first, let me share a real-life example illustrating how useful The Life Stories Exercise can be.

what stocks to buy now: Benchmark Electronics, Inc.(BHE)

Advisors’ Opinion:

  • [By Anders Bylund]

    How do you pick the top names in this broadly lucrative industry? I’m here to show you my three favorites in the printed circuit board market: Sanmina (NASDAQ:SANM), Benchmark Electronics (NYSE:BHE), and TTM Technologies (NASDAQ:TTMI), each one tailor-made for a different type of investor.

what stocks to buy now: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Rich Duprey]

    If a stock falls hard, particularly one with a durable name in its industry, it could be an opportunity to pick up shares on the cheap. But sometimes, a stock trades at a discount for a very good reason, so let’s take a look at Whirlpool (NYSE:WHR), Hanesbrands (NYSE:HBI), and Vista Outdoor (NYSE:VSTO) to see if they are good values at these lower prices — or just value traps.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 1.2% on Wednesday to post a new 52-week low of $21.44 after closing at $21.70 on Tuesday. The stock’s 52-week high is $31.36. Volume was about half the daily average of around 2.6 million shares. The company had no specific news Wednesday.

  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Ben Levisohn]

    Hanesbrands (HBI) tumbled to the bottom of the S&P 500 today after missing earnings forecasts and offering disappointing guidance.

    Agence France-Presse/Getty Images

    Hanesbrandsdropped 16% to $18.98 today, while the S&P 500 rose 0.7% to 2,297.42.

    Stifel’s Jim Duffy and team explain what went wrong:

    Structural changes in US consumer and retail trends weighed on 4Q and HBI fell short in 4Q. These trends are expected to continue in FY17 and guidance was more cautious than prevailing estimates. Given the leverage and dependence on acquisitions for growth, we view visibility to underlying free cash generation key to valuation and we are discouraged by both 2016 results which were well short of plan and the outlook for FY17 operating cash flow which is a step backwards from prior FY16 guidance. With a reduction in 2017 CFO estimates from $795mn to $690mn we are lowering our 12-month target price from $26 to $23.

    Hanesbrands’ market capitalization fell to $7.2 billion today from $8.6 billion yesterday.

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

what stocks to buy now: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Lisa Levin]

    bluebird bio Inc (NASDAQ: BLUE) shares were also up, gaining 22 percent to $209.00 after the company announced updated clinical results from ongoing Phase 1 multicenter study of LentiGlobin gene therapy in severe sickle cell disease at the ASH 2017.

  • [By Todd Campbell]

    After updating investors on its wide-ranging gene therapy research program at a key industry conference early in the month,shares ofbluebird bio(NASDAQ:BLUE) surged 20.7% higher in January,according toS&P Global Market Intelligence.

what stocks to buy now: Canterbury Park Holding Corporation(CPHC)

Advisors’ Opinion:

  • [By Sally Jones]

    Canterbury Park Holding Corporation (CPHC) Market Cap $46.35 Million

    Canterbury Park Holding Corporation is up 2% over 12 months. The company has a market cap of $46.35 million; its trades around $11.16 with a P/E ratio of 59.30 and a P/B of 1.70.

what stocks to buy now: Digital Ally Inc.(DGLY)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Aggressive military and law enforcement spending could be good news for Northrop Grumman Corporation (NYSE: NOC), United Technologies Corporation (NYSE: UTX), Lockheed Martin Corporation (NYSE: LMT), TASER International, Inc. (NASDAQ: TASR) and Digital Ally, Inc. (NASDAQ: DGLY).

  • [By Lisa Levin]

    Digital Ally, Inc. (NASDAQ: DGLY) was down, falling around 13 percent to $2.92. Digital Ally priced 1 million shares equity offering at $3 per share.

  • [By Lisa Levin]

    Digital Ally, Inc. (NASDAQ: DGLY) shares shot up 35 percent to $4.25 after the company reported “significant victory” in its legal battle with Axon Enterprise Inc (NASDAQ: AAXN). The U.S. Patent and Trademark Office (PTO) denied Axon’s petition for inter partes review (IPR) of Digital Ally’s ‘452 patent, one of four IPRs Axon submitted in an attempt to invalidate Digital Ally’s lawsuit. Axon received a favorable PTO ruling on the ‘292 patent, the original point of dispute, in June.

what stocks to buy now: Bunge Limited(BG)

Advisors’ Opinion:

  • [By Casey Wilson]

    Many companies provide the infrastructure needed for farmers to move crops from the farm to the grocery store. Among those are Bunge Ltd. (NYSE: BG), an agribusiness and food company that specializes in the purchase, storage, processing, and transport of agricultural goods. BG is up over 8% year to date and has grown over 1.5% in the past 30 days.

  • [By Steve Symington]

    Shares ofBunge Ltd.(NYSE:BG)rose 10% on Wednesday after the agribusiness and food company released strong fourth-quarter 2016 results.

    So what

    Quarterly revenue grew 8.6% year over year, to $12.1 billion, and translated to 14.1% growth in adjusted earnings per share, to $1.70. Analysts, on average, were only expecting Bunge to report revenue of $11.4 billion and adjusted earnings of $1.57 per share.

  • [By Ben Levisohn]

    Bunge (BG) has dropped 1.5% to $76.14 after getting cut to Underweight from Neutral at JPMorgan.

    L Brands (LB) has jumped 3.9% to $44.80 despite reporting weaker than expected same-store sales.

Best Safest Stocks To Own Right Now

After beating the Q4 earnings, Micron’s (MU) stock price surged. Now is the perfect time to ask, is it still a good time to buy?

I believe so. Micron has solid plans to increase its earnings for next year, groundbreaking proprietary technology with unknown potential, a P/E way below the industry average and reasonable debt. It is a healthy company, heavily undervalued and with little risk.

Valuation

Whether compared to its peers or its earnings growth, Micron has a very low P/E ratio. Although sometimes a low P/E ratio is a sign of a company in distress, this is not the case. The long-term debt to revenue ratio seems acceptable, and even low when compared to its peers. From Q3 to Q4, long-term debt was reduced and this trend is expected to continue.

Best Safest Stocks To Own Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Bryan Murphy]

    To say Fitbit Inc (NYSE:FIT) went from being a hero to being a zero would be a considerable understatement. In 2015 shortly after its IPO, the world was certain its wearable device was going to revolutionize fitness. Less than two years later, you can barely give the things away.

    It’s enough to convince an investor to mentally write-off the idea of wearables forever. Don’t let the rise and fall (and then more fall) of FIT deter you from the industry though. Fitbit had the right idea, more or less. It just failed to adapt and improve even when it became clear its first wave of products weren’t quite what they were hoped to be for the average fitness-minded consumers (a target market that was part of the problem). There’s a young-and-hungry company called CardioComm Solutions Inc. (OTCMKTS:EKGGF, CVE:EKG) that understands exactly why Fitbit was largely sidelines, and this company has responded before committing to products that miss the mark.

    CardioComm Solutions is the name that makes wellness technology sold under the HeartCheck brand. Those devices are small, handheld ECG (electrocardiogram) readers that put the power of a doctor’s or hospital’s heart-monitoring hardware in the hands of individuals who can use them just as effectively. Its flagship products are the HeartCheck ECG Pen, for consumers – which is available without a prescription – and the HeartCheck ECG monitoring device (available only by prescription) which is a higher-functioning technology.

    More products are on the way too. The ECG ‘Card’ is a credit-card sized device that syncs up with (and is powered by) being in close proximity to a smartphone. Also on the way is the HeartCheck band, worn on the wrist. It does a lot of the same things Fitbit bands do, but with the added benefit of being able to produce clinical-grade ECG readouts viewable not just by the user, but by a doctor, clinic, or call center if that user chooses to deliver them remotely using the comp

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) dropped about 0.8% on Monday to post a new 52-week low of $7.42 after closing at $7.48 on Friday. The stock’s 52-week high is $30.96. Volume was 20% below the daily average of around 10 million shares. The company had no specific news Monday.

  • [By Peter Graham]

    Small cap fitnessdevice stock and wearables stockFitbit Inc (NYSE: FIT) started off as a high flyer after its 2015 IPO, but those highflying days have largely ended as you can see from its long term performance chart:

  • [By Bryan Murphy]

    As much progress as the remote medical monitoring device market has made in recent years, we’ve still only scratched the surface. The surface has been scratched though. The Dexcom G5 mobile glucose monitor from DexCom, Inc. (NASDAQ:DXCM) is one impressive example. Arguably the first and best entry in the race, DexCom has sent a clear message that consumers and caregivers are ready for a functional device that takes care of itself.

    At the other end of the spectrum is a recent round of products that are less clinical in nature, and more broad-usage friendly. Devices like the Apple Inc. (NASDAQ:AAPL) watch and the Fitbit Inc (NYSE:FIT) line of products are both capable of monitoring heart rates and activity. On the other, neither does it all that well… not like one would expect in a clinical setting. Fitbit has run into a headwind of legal and reputational trouble since it’s been verified that its trackers aren’t all that accurate; Apple avoided such trouble largely because few consumers ever viewed its watches as medical-grade hardware.

    The gap between the Dexcom G5 and the Fitbit fitness trackers, however, is where real opportunity lies. See, the entries to date have proven there is a market for mobile medical devices , but have also proven they have to work as well as the equipment one might expect to find in a doctor’s office or in a hospital.

    It’s this subtle nuance that puts a young company called Biotricity Inc. (OTCMKTS:BTCY) in the spotlight, as it has melded mobile monitoring and quality monitoring, and is now in the midst of making sure they’re marketable… not just to consumers, but to insurance companies (which tend to pay a lot more than the average consumer does). Fitbit missed the mark on both fronts.

    Biotricity is working two different but similar pieces of technology. One is called bioflux, for use by caregivers in a clinical setting, and the other is biolife individuals outside of a clinical setting. Neither is o

Best Safest Stocks To Own Right Now: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Rich Duprey]

    If a stock falls hard, particularly one with a durable name in its industry, it could be an opportunity to pick up shares on the cheap. But sometimes, a stock trades at a discount for a very good reason, so let’s take a look at Whirlpool (NYSE:WHR), Hanesbrands (NYSE:HBI), and Vista Outdoor (NYSE:VSTO) to see if they are good values at these lower prices — or just value traps.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 1.2% on Wednesday to post a new 52-week low of $21.44 after closing at $21.70 on Tuesday. The stock’s 52-week high is $31.36. Volume was about half the daily average of around 2.6 million shares. The company had no specific news Wednesday.

Best Safest Stocks To Own Right Now: Globalstar Inc.(GSAT)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Globalstar (NYSEMKT:GSAT) has been growing its total sales, but still struggles with its bottom line. 2016 revenue increased 7%,but another round of financing could be needed to keep things afloat, as operating margin is still deep in the red. The company is making some headway, but time could be running out for the satellite communications provider.

Best Safest Stocks To Own Right Now: China Evergrande Group (EGRNF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For example, Evergrande Life – a unit of property developer China Evergrande Group (OTC:EGRNF) – saw its premiums increase more than 40-fold in 2016. It used the proceeds to accumulate a significant stake in rival developer China Vanke (OTC:CVKEY) last year.

Best Safest Stocks To Own Right Now: Dillard's, Inc.(DDS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and largely falling off since then while large cap Macy’s, Inc (NYSE: M) andsmall capDillard’s, Inc (NYSE: DDS)began falling off in 2015 andsmall cap J C Penney Company Inc (NYSE: JCP) was crushed much earlier:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores having two spikes while it along withlarge cap Macy’s, Inc (NYSE: M) and mid capDillard’s, Inc (NYSE: DDS) have posted large declines last year that may or may not have leveled off andsmall cap J C Penney Company Inc (NYSE: JCP) has at least stopped the bleeding:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and has been falling off for a longer period of time thanlarge cap Macy’s, Inc (NYSE: M) andsmall capDillard’s, Inc (NYSE: DDS)whilesmall cap J C Penney Company Inc (NYSE: JCP) was crushed much earlier: